Anabolic effects on rate, composition and energetic efficiency of growth in cattle fed forage and grain diets.
The effects of anabolic implants on rate, composition and energetic efficiency of growth were determined in steers fed diets varying in forage and grain content. Santa Gertrudis-cross steers averaging 337 kg were group-fed (n = 72) or individually fed (n = 45) ad libitum one of three diets and either not implanted or implanted (90-d intervals) with Ralgro or Synovex-S implants. Steers were fed to a similar empty body weight (463 kg). Initial empty body composition of individually fed steers was determined via D2O dilution, and final composition of all steers was determined by carcass specific gravity. Rate of empty body gain increased (P less than .05) from 695 g/d for nonimplanted steers to 798 and 844 g/d for Ralgro- and Synovex-implanted steers. Anabolic implants increased (P less than .01) daily empty body protein gain from 91 to 119 and 133 g for Ralgro and Synovex, an increase of 31 and 46%, respectively. The fraction of protein in empty body gain increased (P less than .01) from 13.8% to 15.6 and 15.9%, and the percentage of fat in empty body gain decreased (P less than .01) from 41.7% to 32.9 and 31.3% with Ralgro and Synovex, respectively. Daily rates of protein deposition increased at a decreasing rate, and rates of fat deposition increased at an increasing rate with increasing rate of empty body gain. Implanted steers deposited more protein and less fat at any rate of growth; the magnitude of this shift in nutrient partitioning from fat to protein growth increased with rate of growth.(ABSTRACT TRUNCATED AT 250 WORDS)
Lemieux
P G
PG
Texas A&M University, College Station 77843.
Byers
F M
FM
Schelling
G T
GT
D000821:Animal Feed; D000818:Animals; D001823:Body Composition / Q000187:drug effects*; D001835:Body Weight / Q000187:drug effects*; D002417:Cattle / Q000254:growth & development*; D004338:Drug Combinations / Q000008:administration & dosage / Q000494:pharmacology; D004343:Drug Implants; D004734:Energy Metabolism / Q000187:drug effects*; D004958:Estradiol / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology; D008297:Male; D011374:Progesterone / Q000008:administration & dosage / Q000494:pharmacology*; D012118:Resorcinols / Q000494:pharmacology*; D015029:Zeranol / Q000008:administration & dosage / Q000494:pharmacology*
D004338:Drug Combinations; D004343:Drug Implants; D012118:Resorcinols; D011374:Progesterone; D004958:Estradiol; D015029:Zeranol; C025370:estradiol benzoate, progesterone drug combination